Merck & Co Inc (NYSE:MRK)

76.48
Delayed Data
As of Dec 14
 -1.98 / -2.52%
Today’s Change
52.83
Today|||52-Week Range
80.19
+35.92%
Year-to-Date
MRK Regular Dividend: MRK began trading ex-dividend on 12/14/18. A $0.55 dividend will be paid to shareholders of record as of 12/17/18.
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Dec 14 / Zacks.com - Paid Partner Content
5 Dow Stocks Stand Tall Despite Index's Loss of 2018 Gains
Dec 13 / Zacks.com - Paid Partner Content
5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019
Dec 14 / Zacks.com - Paid Partner Content
5 Dow Stocks Defying the Index's YTD Plunge
Dec 13 / Zacks.com - Paid Partner Content
J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study
Dec 13 / Zacks.com - Paid Partner Content
Roche to Create Companion Diagnostic Test for Merck's Keytruda
Dec 12 / Zacks.com - Paid Partner Content
Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA
Dec 13 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan
Dec 12 / Zacks.com - Paid Partner Content
Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug
Dec 13 / Zacks.com - Paid Partner Content
Merck (MRK) Outpaces Stock Market Gains: What You Should Know
Dec 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close78.46
Today’s open77.83
Day’s range76.23 - 78.03
Volume13,259,931
Average volume (3 months)10,626,872
Market cap$194.5B
Data as of 4:01pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)-38.03%
Earnings growth (this year)+9.06%
Earnings growth (next 5 years)+8.77%
Revenue growth (last year)+1.23%
P/E ratio61.2
Price/Sales3.87
Price/Book5.87

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-1.01-1.14%
PFEPfizer-0.77-1.73%
ABBVAbbVie-2.10-2.39%
ABTAbbott Laboratories-1.42-1.97%
Data as of 4:03pm ET, 12/14/2018

Financials

Next reporting dateFebruary 1, 2019
EPS forecast (this quarter)$1.05
Annual revenue (last year)$40.0B
Annual profit (last year)$2.4B
Net profit margin5.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts